Intensive Remote Monitoring Versus Conventional Care in Type 1 Diabetes: A Randomized Controlled Trial
Initiatives
-
This study was conducted to assess the impact of an intensive remote therapy (IRT) intervention for pediatric patients with T1D.
Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.
- Start Year
- 2015
- End Year
- 2016
Design
- Study design
- Clinical trial cohort
Marker Paper
Gandrud L, Altan A, Buzinec P, et al. Intensive remote monitoring versus conventional care in type 1 diabetes: A randomized controlled trial [published online ahead of print, 2018 Feb 21]. Pediatr Diabetes. 2018;10.1111/pedi.12654. doi:10.1111/pedi.12654
PUBMED 29464831
Number of participants
- Number of participants
- 117
- Number of participants with biosamples
Access
Availability of data and biosamples
| Data | |
| Biosamples | |
| Other |
Timeline
Pediatric patients with T1D
This was a parallel‐group randomized controlled trial of children and adolescents with T1D recruited from September 14, 2015 to March 3, 2016 from among patients who had been seen in the McNeely Pediatric Diabetes Center at Children's Minnesota (St. Paul, Minnesota) within the past 6 months.
Selection Criteria
- Minimum age
-
8
- Maximum age
-
17
- Newborns
- Twins
- Countries
-
- United States of America
- Ethnic Origin
-
- Health Status
-
- Pediatric patients with T1D
Recruitment
- Sources of recruitment
-
- Clinical patients
Number of participants
- Number of participants
- 117
- Number of participants with biosamples
Data Collection Event
This study was conducted to assess the impact of an intensive remote therapy (IRT) intervention for pediatric patients with T1D.
- Start Date
-
2015-09
- End Date
-
2016-03
- Data sources
-
-
Mobile data collection
- Mobile phone
- Smartphone
- remote sensing, smart sensors
-
Mobile data collection